Return to PJ Online Home Page
The Pharmaceutical Journal Vol 264 No 7095 p684
May 6, 2000 News

MCA requires pharmacists to keep records of supplies of "specials"

Community and hospital pharmacists are to be required to keep records of "specials" that they have supplied to patients for five years. Specials are unlicensed medicines that have been manufactured for specific patients to meet a special need.
The requirement is contained in updated guidance on the manufacture and supply of specials issued by the Medicines Control Agency in February. The guidance says that any person who supplies a special must keep for five years a record of the source of the product, the person to whom it was supplied and the date, the quantity, the batch number and details of any adverse reactions of which he is made aware. These records have to be kept available for inspection by the licensing authority. There is also a requirement to report any serious adverse drug reactions using the yellow card scheme.
After taking legal advice, the MCA has taken the view that specials may only be supplied in order to meet a special patient need, such as intolerance or allergy to an ingredient in a licensed product or inability to swallow a licensed solid dosage form.

specials
New guidance on the manufacture and supply of "Specials" has been produced by the Medicines Control Agency

The MCA says that this puts in question supplies of specials where equivalent licensed products are available.
"If an equivalent licensed medicine is available for use, prescribers will have to identify that the patient has a special need which the special, but not the licensed equivalent, can meet," the Department of Health's acting chief pharmacist (Mrs Jeanette Howe) said in a letter to the Royal Pharmaceutical Society concerning the new guidance.
The guidance says that items dispensed extemporaneously in response to prescriptions or according to pharmacopoeial formulae are not specials. Nor are herbal remedies that are exempt from licensing requirements, homoeopathic products, investigational medicinal products, unlicensed products intended for export, repackaged licensed medicines, and reconstituted intravenous additives.
"The supply of unlicensed relevant medicinal products for individual patients", MCA guidance note 14. Information Centre, Room 1207, Market Towers. 1 Nine Elms Lane Vauxhall, London SW8 5NQ (tel 020 7273 0352, fax 020 7273 0353).